Gary Frazier, Chief Growth Officer at Helio Genomics
What You Should Know:
– Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology for cancer detection, has appointed Gary Frazier as its Chief Growth Officer.
– Frazier’s…
Continue Reading
What You Should Know:
Personalis, Inc., a leader in advanced genomics for cancer, and ClearNote Health, Inc., a pioneer in epigenomic technologies, today unveiled an alliance through which Personalis will expand its pharmaceutical service offerings by…
Continue Reading
By Shania Kennedy
January 30, 2024 – Researchers from City of Hope and its precision medicine research organization, the Translational Genomics Research Institute (TGen), have developed a machine learning (ML) approach that could facilitate the early…
Continue Reading
Explore AI’s evolution, challenges, and breakthroughs at RSNA23. Leaders, including Connie Lehman, MD, PhD, Etta D. Pisano, MD, and Fredrik Strand, MSc, MD, PhD, delve into clinical implementation challenges, cutting-edge research outcomes, and regulatory…
Continue Reading
Paige redefines cancer detection with a groundbreaking AI derived from the Virchow Pathology Foundation Model. This innovation spans over 17 tissue types, including rare tumors and metastatic deposits. By leveraging a vast repository of…
Continue Reading
What You Should Know:
– Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
– Under the terms of the agreement, Veracyte will pay $70…
Continue Reading
Doctors at Englewood Health in New Jersey are using the Ion endoluminal system from Intuitive Surgical to take tissue biopsies from the hard-to-reach outer third of the lung to identify early-stage lung cancer.WHY IT…
Continue Reading
Lunit’s acquisition of Volpara at AUD 1.15 per share marks a pivotal move in cancer diagnostics. The Scheme Implementation Agreement targets Volpara’s AI-enabled solutions, expanding Lunit’s global presence. Volpara’s 100 million mammogram images promise…
Continue Reading
What You Should Know:
– South Korean AI leader Lunit has announced its intention to acquire Volpara, a global pioneer in AI-powered cancer detection software, in a landmark deal worth AUD 292M (USD 193M)….
Continue Reading
RSNA 2023 showcased Koning Health’s groundbreaking Koning Vera Breast CT, revolutionizing breast cancer detection with its unparalleled 3D imaging and biopsy capabilities. The event underscored the urgency for early cancer detection, emphasizing KBCT’s ability…
Continue Reading
